[Agranulocytosis–a complication of the chemotherapy of echinococcosis with mebendazole]. (1992)

Peer-Reviewed Study · Shcherbakov AM, Kozlova TL, Bebris NK · 1992

Shcherbakov AM et al., 1992: Russian series of 75 echinococcosis patients treated with mebendazole 50 mg/kg for 30-day courses, in which two developed agranulocytosis and one died. The authors hypothesise a marrow-toxic effect of high blood concentrations in susceptible patients.

Only two of the 75 patients with echinococcosis, treated with mebendazole in a dose of 50 mg/kg b. m. for 30 days (single course) and administered from 1 to 13 courses with intervals of 1 to 3 months, developed agranulocytosis eventuating in death in one female patient.

Shcherbakov AM et al., 1992: Russian series of 75 echinococcosis patients treated with mebendazole 50 mg/kg for 30-day courses, in which two developed agranulocytosis and one died. The authors hypothesise a marrow-toxic effect of high blood concentrations in susceptible patients. Case series within a treatment cohort; N=75 treated, 2 with agranulocytosis, 1 death; Russia; mebendazole 50 mg/kg/day for 30 days per course, 1-13 courses at 1-3 month intervals. Funder: not stated. Declared conflicts: none recorded. Comparator: none. English abstract of a Russian-language article in Meditsinskaia Parazitologiia; the original-language title is not captured here, so only the bracketed English title is quoted. This is the clearest dose-response anchor for class marrow toxicity at 50 mg/kg. Study type: uncontrolled series.